22 October 2026

---

Philips Sonicare Forms Global Clinical Advisory Board

---

The board brings together 12 international experts with complementary expertise across clinical practice, research, education, behavior change, digital dentistry, and oral health innovation.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in oral healthcare, today announced the formation of the Philips Sonicare Global Clinical Advisory Board, a group of external oral healthcare experts established to help shape the future of Philips Oral Healthcare through science, clinical insight, and meaningful innovation.

The board brings together 12 international experts with complementary expertise across clinical practice, research, education, behavior change, digital dentistry, and oral health innovation. Together, they will provide strategic guidance on emerging trends, support science-led product development, and contribute to further clinical exploration while helping to ensure dental professional perspectives are embedded across the Philips Oral Healthcare product roadmap.

Designed as a long-term collaboration, the board creates an ongoing exchange between Philips Oral Healthcare and global experts to advance evidence-based oral care through science, innovation, and clinical insight.

Oral healthcare is evolving rapidly, with dental professionals and patients looking for clearer guidance, more personalized routines, and solutions grounded in credible clinical and scientific evidence. The Philips Sonicare Global Clinical Advisory Board brings external expertise closer to the innovation process, helping Philips develop oral care solutions that are relevant in clinical practice and support people in their daily routines.

“For more than 55 years, Philips has been an industry leader in oral care, with a heritage rooted in health insights for improved outcomes and meaningful innovation,” said Francesco Grillo, Philips Global Business Unit Leader – Oral Healthcare. “As part of a broader health technology company with deep clinical expertise across consumer health and professional health systems, Philips Oral Healthcare is uniquely positioned to connect dental professional insight with solutions that support better daily oral health. The Philips Sonicare Global Clinical Advisory Board helps us build on that legacy and continue developing evidence-led innovations that meet the needs of professionals and the people they care for.”

“Oral healthcare is entering a new era, shaped by prevention, personalization, digital innovation, and a deeper understanding of how people build healthier routines,” said Andrew Bower, Business Category Leader, Dental Professional & Strategic Adjacencies, Philips Oral Healthcare. “By bringing together experts from different clinical, academic, and regional perspectives, the board will help Philips Sonicare look ahead, anticipate where the profession is moving, and translate expert insight into stronger innovations and, ultimately, better outcomes for consumers and patients.”

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in hospitals and at home.

Headquartered in the Netherlands, the company is a leader in image-guided therapy, diagnostic imaging, ultrasound, monitoring, enterprise informatics, and personal health. Philips generated 2025 sales of approximately EUR 18 billion and employs approximately 63,700 people, with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter .

Source: https://www.philips.com/newscenter